| Dawn Sly, LCSW | |
|
122 Ne 47th St, Newport, OR 97365-1429 | |
| (541) 270-4660 | |
| (541) 895-0977 |
| Full Name | Dawn Sly |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 122 Ne 47th St, Newport, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992938518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 2786 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Sly, LCSW Po Box 898, Creswell, OR 97426-0898 Ph: (541) 270-4660 | Dawn Sly, LCSW 122 Ne 47th St, Newport, OR 97365-1429 Ph: (541) 270-4660 |
News Archive
According to the National Osteoporosis Foundation, 10 million Americans have osteoporosis, and another 18 million have low bone mass, making them at risk for osteoporosis. Often referred to as the silent disease because it develops slowly over a number of years without symptoms, osteoporosis is characterized by a gradual weakening of the bones due to bone loss, which can lead to fractures.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
A team of researchers led by Dr. Michel Cayouette at the IRCM made an important discovery, published online yesterday by the scientific journal Developmental Cell, that could better explain some inherited forms of hearing loss in humans. The Montr-al scientists identified a group of proteins crucial for shaping the cellular organ responsible for detecting sounds.
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
Bacterial contamination in water-damaged buildings has been identified as a potential cause of health problems, including infection and respiratory conditions like asthma. Which specific bacteria contribute to these problems, however, has been unknown-making it difficult for public health officials to develop tools to effectively address the underlying source of the problem.
› Verified 3 days ago
Marah Ann Owecke, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 607 Sw Hurbert St Ste 102, Newport, OR 97365 Phone: 541-270-4717 Fax: 541-272-5112 | |
Jean M Fredrickson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 930 Sw Abbey St, Newport, OR 97365 Phone: 541-574-1811 | |
Ms. Karen Anne-marie Murphy, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 112 Se Douglas St, Newport, OR 97365 Phone: 541-265-1954 Fax: 541-265-6064 | |
John L. Arnold, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1678 N Coast Hwy, Newport, OR 97365 Phone: 541-265-3033 | |
Ms. Rebecca Fransham, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 111 Se Douglas St, Newport, OR 97365 Phone: 541-265-2244 Fax: 541-574-1838 | |
Teresa Jane Goldade, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 405 Se Scenic Loop, Newport, OR 97365 Phone: 541-961-5123 | |
Yarrow Nina Currie, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 36 Sw Nye St, Newport, OR 97365 Phone: 541-265-6611 Fax: 541-574-6252 |